Hydrogen Water

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: inflammation energy detox

Research Overview

Since the first high-profile report in 2007, research on molecular hydrogen (often delivered as hydrogen-rich water, HRW) has expanded rapidly, with hundreds of publications by mid-2015 and continued growth thereafter. The literature is dominated by preclinical studies (mostly mouse and rat models) spanning many organ systems and disease categories, with a recurring focus on conditions characterized by oxidative stress and inflammation. Proposed biological effects extend beyond direct radical scavenging (initially emphasized for hydroxyl radical and peroxynitrite) to modulation of signaling and transcriptional pathways implicated in redox homeostasis and inflammation (e.g., NF-κB-related signaling and multiple kinase cascades). Human studies exist across diverse domains—metabolic health, liver disease, exercise/physical performance, cardiovascular endpoints, and cognitive outcomes—but remain fewer than animal studies and heterogeneous in dosing, duration, and endpoints.

The strongest evidence from the studies reviewed here comes from randomized, double-blind, placebo-controlled trials suggesting potential metabolic benefits in people with metabolic syndrome, where high-concentration HRW was associated with improvements in cardiometabolic risk markers (e.g., cholesterol, glucose, HbA1c) and biomarkers related to inflammation/redox status. Evidence in cognition is suggestive but more conditional: a 1-year trial in mild cognitive impairment did not show an overall between-group difference on the primary cognitive scale, but reported significant improvement in a genetically defined subgroup (APOE4 carriers), indicating a possible effect modification that requires replication. In NAFLD, an 8-week randomized trial reported tolerability and favorable trends in weight/BMI and some biomarkers, but changes were largely non-significant and included unexpected directions for certain oxidative damage markers, underscoring uncertainty about short-term biomarker dynamics and clinical relevance.

Key gaps include the need for larger, well-powered, preregistered clinical trials with standardized HRW preparation (verified dissolved H2 concentration), dosing regimens, and clinically meaningful endpoints, along with longer follow-up to assess durability and safety. Mechanistically, while many downstream molecular changes have been reported, the “master regulator(s)” and primary targets that could explain effects from small amounts of dissolved hydrogen remain unresolved; distinguishing direct antioxidant chemistry from indirect signaling, adaptive (hormetic) responses, and placebo/behavioral effects is an ongoing challenge. Additional research priorities include replication across independent cohorts, clarification of which patient subgroups benefit most (e.g., genetic or baseline oxidative-stress phenotypes), dose–response relationships, and comparative effectiveness versus established lifestyle and pharmacologic interventions.

1. What conditions has Hydrogen Water been studied for?

  • Broad preclinical disease models across many organs: A 2007–2015 literature survey reported effects across 31 disease categories and 166 disease models/human diseases/pathophysiological conditions, with most studies in mice/rats and increasing clinical trials over time. Conditions were described as predominantly oxidative stress–mediated and inflammatory diseases. (Survey abstract)

  • Metabolic syndrome: Studied in a randomized, double-blind, placebo-controlled trial (n=60) using high-concentration hydrogen-rich water (HRW). (Metabolic syndrome RCT abstract)

  • Non-alcoholic fatty liver disease (NAFLD): Studied in a randomized, double-blind, placebo-controlled trial (n=30) for 8 weeks. (NAFLD RCT abstract)

  • Mild cognitive impairment (MCI) / dementia-related outcomes: Studied in an oxidative-stress mouse model and in a randomized double-blind placebo-controlled human study (n=73) over 1 year. (MCI abstract)

  • Traumatic brain injury: Studied in a repetitive mild traumatic brain injury (rmTBI) mouse model, assessing inflammasome/oxidative stress markers, imaging/metabolites, behavior, and cognition. (rmTBI abstract)

  • Parkinson’s disease (PD): Studied indirectly via hydrogen delivery approaches: hydrogen water and lactulose-induced intestinal hydrogen in humans (breath hydrogen) and in a rat PD model; lactulose had only marginal benefit in the rat model. (PD/lactulose abstract)

  • Exercise capacity/physical endurance, cardiovascular disease, mental health, COVID-19, oxidative stress/anti-aging: Listed as areas of interest in a systematic review (25 included articles), without details in the study about specific endpoints or effect sizes. (Systematic review abstract)

  • Pain and inflammatory conditions (preclinical): Electrolyzed hydrogen water (EHW) was described as beneficial in models of inflammatory pain (e.g., sciatic nerve ligation) and inflammatory bowel disease (TNBS model). (EHW review abstract)

2. Does it work in treating those conditions? Summarize the evidence.

  • Metabolic syndrome (human RCT evidence: positive): In a randomized, double-blind, placebo-controlled trial (n=60), high-concentration HRW was reported to significantly reduce blood cholesterol and glucose, attenuate HbA1c, and improve biomarkers of inflammation and redox homeostasis versus placebo. (Metabolic syndrome RCT abstract)

  • NAFLD (human RCT evidence: mostly trends, not statistically significant): In an 8-week randomized, double-blind, placebo-controlled trial (n=30), HRW showed beneficial trends (e.g., ~1 kg weight decrease, BMI trend, lipid profile trend, reduced LDH trend) but p > 0.05 for these phenotypic outcomes; inflammatory signaling markers (NF-κB, HSP70, MMP-9) also tended to decrease non-significantly. Notably, oxidative damage markers (8-OHdG and malondialdehyde) showed a mild, non-significant tendency to increase, which authors suggested could reflect hormesis before longer-term improvements seen elsewhere. (NAFLD RCT abstract)

  • MCI/dementia-related outcomes (human evidence: mixed; subgroup signal): In the 1-year randomized double-blind placebo-controlled study (n=73), there was no significant difference overall in ADAS-cog change between hydrogen-water and placebo. However, in the APOE4 carrier subgroup, the hydrogen-water group showed significant improvement in total ADAS-cog and word recall task scores. (MCI abstract)

  • rmTBI (animal evidence: positive): In a mouse rmTBI model, early HRW intervention was reported to attenuate inflammasome assembly (e.g., NLRP-3 temporal changes) and reduce oxidative stress, with downstream findings consistent with improved myelin/oligodendrocyte-related outcomes and improved depression-like behavior and cognitive impairment compared with rmTBI without HRW. (rmTBI abstract)

  • Parkinson’s disease (animal evidence: unclear for lactulose; hydrogen delivery variability in humans): Hydrogen water increased breath hydrogen rapidly in healthy subjects; lactulose increased breath hydrogen in most healthy subjects but less consistently in PD patients (only 59% increased; 41% showed no increase). In a rat PD model, lactulose only marginally ameliorated PD outcomes. This suggests that raising intestinal hydrogen via lactulose may be less reliable, especially in PD, and benefit in that model was limited. (PD/lactulose abstract)

  • Across many other conditions (evidence base exists but is heterogeneous): The survey abstract reports many studies and organ systems, but also notes that the initial “selective radical scavenging” explanation is insufficient and that master regulator mechanisms remain unclear. The systematic review abstract similarly concludes that preliminary clinical results are encouraging but larger, more rigorous studies are needed. (Survey + systematic review studies)

3. What health benefits does it have?

  • Improved metabolic risk markers (in metabolic syndrome): Reduced cholesterol and glucose, lower HbA1c, and improved inflammation/redox biomarkers versus placebo in an RCT. (Metabolic syndrome RCT abstract)

  • Potential cognitive benefit in a genetically defined subgroup: In MCI, overall ADAS-cog did not differ, but APOE4 carriers improved on total ADAS-cog and word recall. (MCI abstract)

  • Neuroprotection signals in animal models: In oxidative-stress dementia model mice, hydrogen water decreased oxidative stress markers, suppressed memory decline/neurodegeneration, and increased mean lifespan versus controls. In rmTBI mice, HRW improved inflammatory/oxidative pathways and behavioral/cognitive outcomes. (MCI + rmTBI studies)

  • Anti-inflammatory and redox-modulating effects (mechanistic/biomarker level): Multiple studies describe attenuation of oxidative stress and inflammation and modulation of signaling pathways (e.g., NF-κB-related markers; and broader signaling molecules such as ERK/p38/JNK/STAT3 and others listed in the survey). (Survey + NAFLD + EHW studies)

  • Possible liver-related benefits (NAFLD: suggestive but not proven in this short trial): Trends toward improved weight/BMI and lipid-related markers without worsening liver enzymes over 8 weeks, but not statistically significant. (NAFLD RCT abstract)

4. Does it have any downsides or side effects?

  • Generally described as low risk in principle: One abstract argues hydrogen is “mild” and should have “little adverse effects” because it does not disrupt metabolic redox reactions or ROS involved in signaling (this is a mechanistic rationale, not a definitive safety trial conclusion). (Antioxidant rationale abstract)

  • NAFLD trial: well-tolerated, but unexpected biomarker direction: HRW was reported as well-tolerated with no significant changes in liver enzymes. However, there was a mild, non-significant tendency toward increased 8-OHdG and malondialdehyde (oxidative damage markers) in the HRW group; authors speculated this might reflect hormetic effects rather than harm, but the finding highlights uncertainty and the need for longer and larger studies. (NAFLD RCT abstract)

  • Evidence limitations are a practical downside: The survey notes most evidence is from animal studies; the systematic review emphasizes that larger sample sizes and rigorous methodologies are needed and mechanisms are not fully explained. This means real-world benefit and long-term safety remain incompletely characterized for many claimed uses. (Survey + systematic review studies)

  • Hydrogen delivery variability: In the PD/lactulose study, lactulose-induced hydrogen production was less consistent in PD patients than healthy controls, suggesting that some approaches to increasing hydrogen exposure may be unreliable in certain populations. (PD/lactulose abstract)

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

  • APOE4 (potentially beneficial signal in MCI): In the randomized controlled MCI study, the overall group did not significantly differ, but APOE4 carriers in the hydrogen-water group showed significant improvement in total ADAS-cog and word recall task scores after 1 year. This suggests a possible genotype-specific benefit, but it is based on a subgroup analysis and should be considered hypothesis-generating until replicated. (MCI abstract)

  • No other specific genetic variants identified in these studies: Beyond APOE4, the studies reviewed here do not report clear pharmacogenomic harms/benefits for other genotypes. (All studies)

References

  1. Beneficial biological effects and the underlying mechanisms of molecular hydrogen - comprehensive review of 321 original articles.
    Masatoshi Ichihara, Sayaka Sobue, Mikako Ito, Masafumi Ito, Masaaki Hirayama, Kinji Ohno (2015) - Medical gas research
  2. Hydrogen Water: Extra Healthy or a Hoax?-A Systematic Review.
    Gagandeep Dhillon, Venkata Buddhavarapu, Harpreet Grewal, Pranjal Sharma, Ram Kishun Verma, Ripudaman Munjal, Ramprakash Devadoss, Rahul Kashyap (2024) - International journal of molecular sciences
  3. Recent progress toward hydrogen medicine: potential of molecular hydrogen for preventive and therapeutic applications.
    Shigeo Ohta (2011) - Current pharmaceutical design
  4. The Effects of 24-Week, High-Concentration Hydrogen-Rich Water on Body Composition, Blood Lipid Profiles and Inflammation Biomarkers in Men and Women with Metabolic Syndrome: A Randomized Controlled Trial.
    Tyler W LeBaron, Ram B Singh, Ghizal Fatima, Kumar Kartikey, Jagdish P Sharma, Sergej M Ostojic, Anna Gvozdjakova, Branislav Kura, Mami Noda, Viliam Mojto, Mohammad Arif Niaz, Jan Slezak (2020) - Diabetes, metabolic syndrome and obesity : targets and therapy
  5. Biological Effects of Hydrogen Water on Subjects with NAFLD: A Randomized, Placebo-Controlled Trial.
    Branislav Kura, Maria Szantova, Tyler W LeBaron, Viliam Mojto, Miroslav Barancik, Barbara Szeiffova Bacova, Barbora Kalocayova, Matus Sykora, Ludmila Okruhlicova, Narcisa Tribulova, Anna Gvozdjakova, Zuzana Sumbalova, Jarmila Kucharska, Xenia Faktorova, Martina Jakabovicova, Zuzana Durkovicová, Jan Macutek, Michaela Koscová, Jan Slezak (2022) - Antioxidants (Basel, Switzerland)
  6. Effects of Molecular Hydrogen Assessed by an Animal Model and a Randomized Clinical Study on Mild Cognitive Impairment.
    Kiyomi Nishimaki, Takashi Asada, Ikuroh Ohsawa, Etsuko Nakajima, Chiaki Ikejima, Takashi Yokota, Naomi Kamimura, Shigeo Ohta (2018) - Current Alzheimer research
  7. Enhanced Removal of Free Radicals by Aqueous Hydrogen Nanobubbles and Their Role in Oxidative Stress.
    You Zhang, Wenhong Fan, Xiaomin Li, Wen-Xiong Wang, Shu Liu (2022) - Environmental science & technology
  8. Health Benefits of Electrolyzed Hydrogen Water: Antioxidant and Anti-Inflammatory Effects in Living Organisms.
    Di Hu, Shigeru Kabayama, Yasuyoshi Watanabe, Yilong Cui (2024) - Antioxidants (Basel, Switzerland)
  9. Decoupling the mutual promotion of inflammation and oxidative stress mitigates cognitive decline and depression-like behavior in rmTBI mice by promoting myelin renewal and neuronal survival.
    Shenghua Lu, QianQian Ge, MengShi Yang, Yuan Zhuang, Xiaojian Xu, Fei Niu, Baiyun Liu, Runfa Tian (2024) - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
  10. Drinking hydrogen water and intermittent hydrogen gas exposure, but not lactulose or continuous hydrogen gas exposure, prevent 6-hydorxydopamine-induced Parkinson's disease in rats.
    Mikako Ito, Masaaki Hirayama, Kazuaki Yamai, Sae Goto, Masafumi Ito, Masatoshi Ichihara, Kinji Ohno (2012) - Medical gas research
  11. Effects of concomitant use of hydrogen water and photobiomodulation on Parkinson disease: A pilot study.
    Chien-Tai Hong, Chaur-Jong Hu, Hung-Yu Lin, Dean Wu (2021) - Medicine
  12. Hydrogen-water ameliorates radiation-induced gastrointestinal toxicity via MyD88's effects on the gut microbiota.
    Hui-Wen Xiao, Yuan Li, Dan Luo, Jia-Li Dong, Li-Xin Zhou, Shu-Yi Zhao, Qi-Sheng Zheng, Hai-Chao Wang, Ming Cui, Sai-Jun Fan (2018) - Experimental & molecular medicine
  13. Drinking hydrogen water enhances endurance and relieves psychometric fatigue: a randomized, double-blind, placebo-controlled study
    Toshio Mikami, Kohei Tano, Hosung Lee, Hyowon Lee, Jonghyuk Park, Fumiaki Ohta, Tyler W LeBaron, Shigeo Ohta (2019) - Canadian journal of physiology and pharmacology
  14. Electrolyzed-Reduced Water: Review I. Molecular Hydrogen Is the Exclusive Agent Responsible for the Therapeutic Effects.
    Tyler W LeBaron, Randy Sharpe, Kinji Ohno (2022) - International journal of molecular sciences
  15. Treatment of hydrogen molecule abates oxidative stress and alleviates bone loss induced by modeled microgravity in rats.
    Y Sun, F Shuang, D M Chen, R B Zhou (2013) - Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
  16. Hydrogen Water Drinking Exerts Antifatigue Effects in Chronic Forced Swimming Mice via Antioxidative and Anti-Inflammatory Activities.
    Jesmin Ara, Ailyn Fadriquela, Md Faruk Ahmed, Johny Bajgai, Ma Easter Joy Sajo, Sung Pyo Lee, Tae Su Kim, Jin Young Jung, Cheol Su Kim, Soo-Ki Kim, Kwang Yong Shim, Kyu-Jae Lee (2018) - BioMed research international
  17. Oral 'hydrogen water' induces neuroprotective ghrelin secretion in mice.
    Akio Matsumoto, Megumi Yamafuji, Tomoko Tachibana, Yusaku Nakabeppu, Mami Noda, Haruaki Nakaya (2013) - Scientific reports
  18. Application of Electrolyzed Hydrogen Water for Management of Chronic Kidney Disease and Dialysis Treatment-Perspective View.
    Masaaki Nakayama, Shigeru Kabayama, Mariko Miyazaki (2024) - Antioxidants (Basel, Switzerland)
  19. Inhalation of hydrogen gas elevates urinary 8-hydroxy-2'-deoxyguanine in Parkinson's disease.
    Masaaki Hirayama, Mikako Ito, Tomomi Minato, Asako Yoritaka, Tyler W LeBaron, Kinji Ohno (2018) - Medical gas research
  20. Quantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson's disease.
    Anzu Suzuki, Mikako Ito, Tomonori Hamaguchi, Hiroshi Mori, Yuka Takeda, Ryuko Baba, Takeshi Watanabe, Ken Kurokawa, Susumu Asakawa, Masaaki Hirayama, Kinji Ohno (2018) - PloS one


Related

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!